Elvitegravir

CHEMBL204656 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

447.9 g/mol

LogP

5.3

Phase

4

This antiviral medication blocks an enzyme that the HIV virus needs to insert its genetic material into human cells. It is always used as part of a combination antiretroviral therapy regimen.

Moleküler Ağırlık

447,9000 g/mol

LogP

5,30

TPSA

87,10 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Generalized Anxiety Disorder Hypertension HIV/AIDS Hepatitis C

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C

InChI

InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1

Molecular Formula

C23H23ClFNO5

HBD / HBA

2 / 7

Döndürülebilir Bağlar

7

Ağır Atomlar

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This antiviral medication blocks an enzyme that the HIV virus needs to insert its genetic material into human cells. It is always used as part of a combination antiretroviral therapy regimen.

Yes, Elvitegravir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL204656. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5277135. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Elvitegravir PillFYI'da

Yapı

Hızlı Veriler

Formül: C23H23ClFNO5
Eş Anlamlılar: 2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.